Ben Tre Pharmaceutical JSC (DBT)

Currency in VND
13,100.0
+50.0(+0.38%)
Closed·
Advertisement

Ben Tre Pharmaceutical JSC (DBT) Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell

Technical Indicators

Strong Sell

Moving Averages

Sell

Summary:Strong Sell

Moving Averages:SellBuy: (5)Sell: (7)
Technical Indicators:Strong SellBuy: (0)Sell: (7)

Technical Indicators

Summary: Strong SellBuy: 2Neutral: 0Sell: 6
Aug 12, 2026 10:21 GMT
Name
Value
Action
RSI(14)39.403Sell
STOCH(9,6)85.12Overbought
STOCHRSI(14)7.279Oversold
MACD(12,26)-47.3Sell
ADX(14)63.029Buy
Williams %R-20.508Buy
CCI(14)-87.1648Sell
ATR(14)78.5714Less Volatility
Highs/Lows(14)-267.8571Sell
Ultimate Oscillator17.143Oversold
ROC-4.727Sell
Bull/Bear Power(13)-363.422Sell

Moving Averages

Summary: SellBuy: 5Sell: 7
Aug 12, 2026 10:21 GMT
Name
Simple
Exponential
MA5
13090.0
Buy
13143.5
Sell
MA10
13250.0
Sell
13230.7
Sell
MA20
13442.5
Sell
13319.0
Sell
MA50
13228.0
Sell
13222.3
Sell
MA100
12901.5
Buy
12966.8
Buy
MA200
12538.2
Buy
12580.9
Buy

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic13033.413066.713083.413116.713133.413166.713183.4
Fibonacci13066.713085.813097.613116.713135.813147.613166.7
Camarilla13086.213090.813095.413116.713104.613109.213113.8
Woodie's1302513062.51307513112.51312513162.513175
DeMark's--1307513112.513125--

FAQ

Is Ben Tre Pharmaceutical JSC (DBT) a Buy or Sell, from a Technical Analysis Perspective?

Based on moving averages and other technical indicators, today's Ben Tre Pharmaceutical JSC buy/sell signal is Neutral.

What Do The Current Moving Averages for Ben Tre Pharmaceutical JSC (DBT) Show?

The moving averages for Ben Tre Pharmaceutical JSC show a Buy outlook, considering moving averages ranging from MA5 to MA200, with 8 Buy signals and 4 Sell signals.

What Do Today's Technical Indicators for Ben Tre Pharmaceutical JSC Show?

The technical indicators for Ben Tre Pharmaceutical JSC are in a Neutral position based on daily analysis, with 2 signals on buy indicators and 5 sell signals.

What Is Ben Tre Pharmaceutical JSC (DBT)'s 14-Day RSI?

The current Relative Strength Index (RSI) of DBT over the 14-day period is 39.403, which suggests that the stock is a Sell.

What Is Ben Tre Pharmaceutical JSC (DBT)'s MACD?

DBT's MACD (Moving Average Convergence/Divergence) is -47.300, which suggests that the stock is a Sell.

What Is Ben Tre Pharmaceutical JSC (DBT)'s 5-Day Moving Average?

DBT's 5-day moving average is 13090.0, suggesting that the stock is a Buy.

What Is Ben Tre Pharmaceutical JSC (DBT)'s 50-Day Moving Average?

DBT's 50-day moving average is 13228.0, suggesting that the stock is a Sell.

What Is Ben Tre Pharmaceutical JSC (DBT)'s 200-Day Moving Average?

DBT's 200-day moving average is 12538.2, suggesting that the stock is a Buy.

What Is the Fibonacci Pivot Point Performance Value for Ben Tre Pharmaceutical JSC (DBT)?

The Fibonacci pivot point performance value for DBT is 13116.7.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.